ETC
NUVB icon

Exchange Traded Concepts’s Nuvation Bio NUVB Stock Holding History

Exchange Traded Concepts’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,951
Closed -$107K – 1478
2025
Q1 		$107K Buy
60,951
+6,403
+12% +$14.6K ﹤0.01% 1136
2024
Q4 		$145K Hold
54,548
– – ﹤0.01% 1065
2024
Q3 		$125K Sell
54,548
-44,684
-45% -$136K ﹤0.01% 1109
2024
Q2 		$290K Sell
99,232
-30,875
-24% -$94.2K 0.01% 829
2024
Q1 		$474K Buy
130,107
+22,264
+21% +$42.8K 0.01% 661
2023
Q4 		$163K Buy
107,843
+27,346
+34% +$35.2K ﹤0.01% 819
2023
Q3 		$108K Buy
80,497
+641
+0.8% +$1.07K ﹤0.01% 872
2023
Q2 		$144K Buy
+79,856
New +$136K ﹤0.01% 851

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Exchange Traded Concepts's NUVB Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Nuvation Bio (NUVB) in Q2 2025, closing a stake of 60,951 shares — an estimated $107K sold.

Exchange Traded Concepts first reported a position in NUVB in Q2 2023 and held it in 8 quarters. The position peaked at $474K in Q1 2024. 182 funds tracked by Wall St. Rank hold NUVB as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Nuvation Bio position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 60,951 Nuvation Bio shares in Q2 2025, an estimated $107K.
  • Exchange Traded Concepts first reported a position in Nuvation Bio in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Nuvation Bio position peaked at $474K in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.